Details for Patent: 10,669,236
✉ Email this page to a colleague
Which drugs does patent 10,669,236 protect, and when does it expire?
Patent 10,669,236 protects KLISYRI and is included in one NDA.
This patent has seventeen patent family members in thirteen countries.
Summary for Patent: 10,669,236
Title: | Solid forms of 2-(5-(4-(2-morpholinoethoxy)phenyl)pyridin-2-yl)-N-benzylacetamide |
Abstract: | The present application provides solid Forms A, B, and C of 2-(5-(4-(2-morpholinoethoxy)phenyl)pyridin-2-yl)-N-benzylacetamide, and methods of preparing and using same. The compounds disclosed herein may be used in the treatment or prevention of a disease or condition in which a tyrosine kinase plays a role. |
Inventor(s): | Smolinski; Michael P. (Amherst, NY) |
Assignee: | Athenex HK Innovative Limited (Sha Tin, HK) |
Application Number: | 16/124,281 |
Patent Claim Types: see list of patent claims | Composition; Compound; |
Drugs Protected by US Patent 10,669,236
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Almirall | KLISYRI | tirbanibulin | OINTMENT;TOPICAL | 213189-001 | Dec 14, 2020 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | Y | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 10,669,236
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Australia | 2018330163 | ⤷ Try a Trial | |||
Australia | 2023201010 | ⤷ Try a Trial | |||
Brazil | 112020004419 | ⤷ Try a Trial | |||
Canada | 3074831 | ⤷ Try a Trial | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |